Merck faces a class-action lawsuit over alleged misrepresentation of its mumps vaccine potency, claiming anticompetitive ...

Merck is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

Innovative technology represents a breakthrough scientific achievement for one of the most common feline infectious diseases RAHWAY, N.J., September 24, 2024--(BUSINESS WIRE)--Merck Animal Health ...

(RTTNews) - Merck Animal Health ... The newly USDA-approved vaccine platform will be available at veterinary clinics and hospitals across the nation this fall. Notably, the same RNA-particle ...

Merck & Co. escaped antitrust claims by a group physicians who alleged that they bought the company’s mumps vaccine at inflated prices because it deceived the government to maintain its monopoly on ...

Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines. This expansion of their 2016 collaboration will ...

The German veterinary vaccines market is poised for significant growth, projected to achieve a compound annual growth rate ...

These blue chip dividend stocks would be ideal for investors who had to hold them forever. They provide reliable streams of ...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

RAHWAY, N.J., October 09, 2024--New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio RAHWAY, N.J., October 08 ...